The US IC device market will continue to be negatively affected by policies that contribute to declining ASPs, such as Medicare coverage for low-complexity catheterization procedures performed in nonhospital facilities, reimbursement equalization between different sites of service, and cost-containment measures. However, these effects will be mitigated by rising procedure volumes, particularly for complex CAD, as well as the emergence of specialized premium-priced technologies to treat these complex cases.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the US, with market projections across a 10-year period.
A number of flagship DES devices were launched in recent years in the highly competitive DES market.
How have market dynamics changed between the three major competitors in 2019?
How has BIOTRONIK's Orsiro performed in the US market since its launch?
What competitive strategies are major competitors taking to gain market share in this market?
What is the developmental pipeline for the next generation of BRS?
The CMS continues to announce additional changes to Medicare coverage and reimbursement that will affect the IC device market in the coming years.
How have the first years of MACRA implementation affected the IC device market?
How will proposed rules in 2020 influence changes in site of service for PCI procedures?
What changes in reimbursement are expected to influence IC practices?
Emerging technologies designed to diagnose and treat complex PCIs are expected to receive approval in the US in the near future.
How will the adoption of alternative coronary physiology modalities such as resting indices, angiography-based FFR, and noninvasive FFRCT alter patient and procedure compositions in cardiac catheterization labs?
What is the status and expected impact of emerging balloon-based technologies such as DCBs and coronary lithotripsy?
Table of contents
- United States
- Abstract
- Executive Summary
- Market Highlights
- Competitive Highlights
- Market Developments
- End-User Insights
- Procedures Covered
- Products Covered
- Key Report Updates
- Interventional Cardiology Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Clinical Data
- Pricing Strategies and Purchasing Options
- Product Improvements and Innovations
- Mergers, Acquisitions, and Partnerships
- Physician Training and Marketing
- Emerging Technologies
- Sites of Service
- Market Developments
- Coronary Stent Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Product Improvements and Innovations
- Mergers, Acquisitions, and Partnerships
- Emerging Technologies
- PTCA Balloon Catheter Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Accessory Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Pricing Strategies and Purchasing Options
- Product Improvements and Innovations
- Physician Training and Marketing
- Intravascular Imaging Catheter and Pressure Guidewire Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Clinical Data
- Pricing Strategies and Purchasing Options
- Coronary Atherectomy Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Thrombectomy and Thrombolysis Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- Competitive Highlights
- Market Shares
- Competitive Factors and Strategies
- Appendix
- Abbreviations
- Bibliography
Author(s): Michael Tian, PhD
Michael Tian is a senior analyst within the Cardiovascular Medtech Insights team at Decision Resources Group and is an expert in interventional cardiology, cardiac surgery, vascular access, and interventional oncology device markets. Michael spends much of his time exploring and translating large claims and hospital purchase datasets into intriguing stories within the global MedTech market, and he is always looking for the next challenging question to tackle. Michael holds a in Physiology and Neuroscience from the University of Toronto.